Journal of Chemistry

Journal of Chemistry / 2010 / Article

Open Access

Volume 7 |Article ID 120417 | https://doi.org/10.1155/2010/120417

R. Vijayalakshmi, P. Bhargavi, P. Srujana Kumari, P. Sruthi, M. D. Dhanaraju, "Spectrophotometric Determination of Ceftibuten in Bulk and in Pharmaceutical Formulations", Journal of Chemistry, vol. 7, Article ID 120417, 4 pages, 2010. https://doi.org/10.1155/2010/120417

Spectrophotometric Determination of Ceftibuten in Bulk and in Pharmaceutical Formulations

Received21 Jul 2009
Accepted10 Sep 2009

Abstract

A simple and cost effective spectrophotometric method is described for the determination of ceftibuten in pure form and in pharmaceutical formulations. The method is based on the formation of blue colored chromogen, when the drug reacts with Folin-Ciocalteu (F-C) reagent in alkaline medium. The colored species has an absorption maximum at 798 nm and obeys Beer’s law in the concentration range 10-50 mcg/mL. The apparent molar absorptivity and sandell’s sensitivity were 0.4583x104 and 0.3x104 respectively. The slope and intercept of the equation of the regression line are 4.5x10-3 and 1.3x10-5 respectively. The optimum experimental parameters for the reaction have been studied and the validity of the described procedure was assessed. Statistical analysis of the results has been carried out revealing high accuracy and good precision. The proposed method was successfully applied for the determination of ceftibuten in pharmaceutical formulations.

Copyright © 2010 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views362
Downloads732
Citations

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.